Pacira BioSciences Q3 EPS $0.48 Beats $0.33 Estimate, Sales $104.685M Miss $104.89M Estimate

Pacira BioSciences (NASDAQ:PCRX) reported quarterly earnings of $0.48 per share which beat the analyst consensus estimate of $0.33 by 45.45 percent. This is a 54.84 percent increase over earnings of $0.31 per share from

Benzinga · 11/07/2019 14:40

Pacira BioSciences (NASDAQ:PCRX) reported quarterly earnings of $0.48 per share which beat the analyst consensus estimate of $0.33 by 45.45 percent. This is a 54.84 percent increase over earnings of $0.31 per share from the same period last year. The company reported quarterly sales of $104.685 million which missed the analyst consensus estimate of $104.89 million by 0.20 percent. This is a 25.45 percent increase over sales of $83.448 million the same period last year.